Palvella Therapeutics Q3 EPS $(1.70) Beats $(1.82) Estimate
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings Beats
Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.70) per share which beat the analyst consensus estimate of $(1.82) by 6.59 percent. This is a 65.05 percent decrease over losses of $(1.03) per share
Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.70) per share which beat the analyst consensus estimate of $(1.82) by 6.59 percent. This is a 65.05 percent decrease over losses of $(1.03) per share from the same period last year.